Figure 3From: Phase I/II clinical trial of enzyme replacement therapy with idursulfase beta in patients with mucopolysaccharidosis II (Hunter Syndrome) Plasma concentration of test drugs in Korean male patients with Mucopolysaccharidosis II Squares represent the comparator at 0.5 mg/kg/week group (N = 2), closed circles represent the idursulfase beta 0.5 mg/kg/week group (N = 2), and open circles represent the idursulfase beta 1.0 mg/kg/week group (N = 2). Back to article page